Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01565551 · ClinicalTrials.gov registry record

Transforming Research and Clinical Knowledge in TBI Pilot

A clinical trial, sponsored by University of California, San Francisco.

Completed
Registry status
650
Enrollment target

NCT01565551: Completed study, sponsored by University of California, San Francisco.

NCT01565551 is a clinical trial that has completed, run by University of California, San Francisco. The registered enrollment target is 650 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01565551 has completed, sponsored by University of California, San Francisco.

COMPLETED
Registry status
650 participants
Enrollment target

Study Summary

The global aim of this proposal is to test and refine Common Data Elements (CDEs), neuroimaging standards, and best practices for genetics and proteomics in Traumatic Brain Injury (TBI) studies. Testing and validating of TBI-CDEs will be performed in a multi-center prospective observational study with 3 TBI Centers (San Francisco General Hospital (SFGH), University of Pittsburgh Medical Center (UPMC), University Medical Center Brackenridge (UMCB)) and a TBI Rehabilitation Center (Mount Sinai Rehabilitation Center (MSMC)). The investigators will create and expand existing data repositories for patient demographics, neuroimaging, plasma biomarkers, genetics, and multivariate outcomes thereby providing researchers and clinicians with the infrastructure to establish multidisciplinary, multicenter research networks and improve clinical research in the TBI field.

Primary Outcome

The GOSE provides and overall measure of disability based on information on cognition, independence, employability, and social/community participation collected via structured interview. Individuals are described by one of the eight outcome categories: Dead (1); Vegetative State (2); Lower Severe Disability (3); Upper Severe Disability (4); Lower Moderate Disability (5); Upper Moderate Disability (6); Lower Good Recovery (7) and Upper Good Recovery (8). Good Recovery is defined as a score of 7-8

Interventions

  • OTHER N/A (Observational Study)

Trial Details

FieldValue
Enrollment Target 650 participants
Start Date 2010-04
Est. Completion 2013-12

What the finished NCT01565551 record still lists

NCT01565551 is an observational study that tracks outcomes without assigning an intervention. The registered 650 participants enrollment target is mid-sized for trials with a published cap.

The record links to 0 conditions, and to 1 intervention - of which N/A (Observational Study) is the first listed.

NCT01565551 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01565551 about?

NCT01565551 is a clinical study titled "Transforming Research and Clinical Knowledge in TBI Pilot". The global aim of this proposal is to test and refine Common Data Elements (CDEs), neuroimaging standards, and best practices for genetics and proteomics in Traumatic Brain Injury (TBI) studies. Testing and validating of TBI-CDEs will be performed in a multi-center prospective observational study wi...

What is the current status of trial NCT01565551?

This trial is currently completed. The enrollment target is 650 participants. The study started on 2010-04. Estimated completion is 2013-12.

What interventions are being tested in trial NCT01565551?

The interventions under investigation include: N/A (Observational Study) (OTHER).

Who is sponsoring clinical trial NCT01565551?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02934477 · 650 participants

    Prospective Assessment of Allogeneic Hematopoietic Cell Transplantation in Patients With Myelofibrosis

  • NCT04579120 · 650 participants

    Neuroimaging in Healthy Aging and Senile Dementia (HASD_IND)

  • NCT04875702 · 650 participants · Phase 4

    Treat-to-Target Serum Urate Versus Treat-to-Avoid Symptoms in Gout

  • NCT05046600 · 650 participants

    Registry of Arthrex Hand and Wrist Products

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01565551, the US trial registry maintained by the National Library of Medicine. NCT01565551 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.